To further confirm that SEPT9 was a crucial effector of CDC42EP5 function in melanoma, we next investigated whether elevating Sept9 activity was sufficient to rescue the functional defects associated with loss of Cdc42ep5. The gene discussed is SEPTIN9; the disease is melanoma.